Skip to main content
PMC home page
Sarcoma logoLink to Sarcoma
. 2000 Dec 22;4(4):173–177. doi: 10.1155/2000/575781

Confirmed Angiosarcoma: Prognostic Factors and Outcome in 50 Prospectively Followed Patients

N J Espat 1,4,*, J J Lewis 1, J M Woodruff 2, C Antonescu 2, J Xia 2, D Leung 3, Brennan M F 1
PMCID: PMC2395443  PMID: 18521298

Abstract

Purpose. Angiosarcoma is a rare tumor with endothelial cell differentiation that may arise in any anatomic location.The purpose of this report was to identify prognostic factors on outcome in a group of prospectively followed patients with confirmed angiosarcoma.

Subjects. Adult patients (>16 years old) with angiosarcoma treated between July 1982 and February 1998 were identified from a prospective database.

Methods. Pathologic confirmation of all cases was performed prior to inclusion in this analysis. Various prognostic factors were evaluated for disease-specific survival. Survival was determined by the Kaplan– Meier method. Statistical significance was evaluated by log-rank test for univariate analysis and Cox stepwise regression for multivariate analysis (p < 0.05).

Results. Fifty patients were identified; at the initial evaluation, this group included 32 patients with a primary tumor, three with local recurrence and 15 with metastatic disease. Tumor sites included 16 head and neck and skin of head, eight extremity, seven trunk, six breast, five pelvis, four viscera and four thoracic. Median follow-up among survivors was 71 months (range, 38–191 months).Two- and 5-year disease-specific survival was 50 and 30%, respectively, with a median of 24 months. The factor predictive of tumor-related mortality was presentation status (p=0.001; relative risk, 5). Two-year disease-specific survival for patients presenting with recurrent or metastatic disease was 13%, compared with 70% for those with primary disease.

Full Text

The Full Text of this article is available as a PDF (92.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brennan M. F., Casper E. S., Harrison L. B., Shiu M. H., Gaynor J., Hajdu S. I. The role of multimodality therapy in soft-tissue sarcoma. Ann Surg. 1991 Sep;214(3):328–338. doi: 10.1097/00000658-199109000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brennan M. F. The enigma of local recurrence. The Society of Surgical Oncology. Ann Surg Oncol. 1997 Jan;4(1):1–12. doi: 10.1007/BF02316804. [DOI] [PubMed] [Google Scholar]
  3. Donnell R. M., Rosen P. P., Lieberman P. H., Kaufman R. J., Kay S., Braun D. W., Jr, Kinne D. W. Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol. 1981 Oct;5(7):629–642. doi: 10.1097/00000478-198110000-00005. [DOI] [PubMed] [Google Scholar]
  4. Giuliano A. E., Eilber F. R. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol. 1985 Oct;3(10):1344–1348. doi: 10.1200/JCO.1985.3.10.1344. [DOI] [PubMed] [Google Scholar]
  5. Karpeh M. S., Jr, Caldwell C., Gaynor J. J., Hajdu S. I., Brennan M. F. Vascular soft-tissue sarcomas. An analysis of tumor-related mortality. Arch Surg. 1991 Dec;126(12):1474–1481. doi: 10.1001/archsurg.1991.01410360044008. [DOI] [PubMed] [Google Scholar]
  6. Lewis J. J., Brennan M. F. Soft tissue sarcomas. Curr Probl Surg. 1996 Oct;33(10):817–872. [PubMed] [Google Scholar]
  7. Lewis J. J., Leung D., Heslin M., Woodruff J. M., Brennan M. F. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997 Feb;15(2):646–652. doi: 10.1200/JCO.1997.15.2.646. [DOI] [PubMed] [Google Scholar]
  8. Lydiatt W. M., Shaha A. R., Shah J. P. Angiosarcoma of the head and neck. Am J Surg. 1994 Nov;168(5):451–454. doi: 10.1016/s0002-9610(05)80097-2. [DOI] [PubMed] [Google Scholar]
  9. Maddox J. C., Evans H. L. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer. 1981 Oct 15;48(8):1907–1921. doi: 10.1002/1097-0142(19811015)48:8<1907::aid-cncr2820480832>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Naka N., Ohsawa M., Tomita Y., Kanno H., Uchida A., Aozasa K. Angiosarcoma in Japan. A review of 99 cases. Cancer. 1995 Feb 15;75(4):989–996. doi: 10.1002/1097-0142(19950215)75:4<989::aid-cncr2820750414>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  11. Naka N., Ohsawa M., Tomita Y., Kanno H., Uchida A., Myoui A., Aozasa K. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996 Mar;61(3):170–176. doi: 10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  12. Taghian A., de Vathaire F., Terrier P., Le M., Auquier A., Mouriesse H., Grimaud E., Sarrazin D., Tubiana M. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):361–367. doi: 10.1016/0360-3016(91)90783-z. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES